South Korea Pediatric Medical Devices Market Overview, 2031

Key Insights

• According to the research report, "South Korea Pediatric Medical Devices Market Outlook, 2031," published by Bonafide Research, the South Korea Pediatric Medical Devices Market is anticipated to add to more than 162.86 Million by 2026-31.
• In 2025, South Korea implemented the dedicated Digital Medical Products Act, creating a separate fast-track approval pathway for AI-driven software, Software as a Medical Device (SaMD), and digital therapeutics distinct from conventional hardware. Driven by this shift, AI-based medical device registrations with the Ministry of Food and Drug Safety (MFDS) quadrupled between 2021 and 2025. In pediatric care, this framework accelerates the domestic deployment of AI diagnostic algorithms, pediatric SaMD, and smart telemetry tools designed for early detection of pediatric conditions without subjecting pediatric patients to invasive testing.
• South Korea faces extreme demographic pressures, with its total fertility rate dropping to a record low of 0.72 births per woman and total annual births falling below 230,000. Despite a declining pediatric population base, the intensity of healthcare spending per pediatric patient remains exceptionally high. Government health expenditure exceeds 8.0% of GDP, and tertiary university hospitals maintain an ultra-high concentration of advanced pediatric technologies such as ECMO units, robotic surgery systems, and neonatal continuous monitoring to optimize survival rates and long-term health outcomes for high-risk neonates.
• South Korean MedTech innovators have introduced specialized procedural and diagnostic breakthroughs for young patients. A notable milestone includes domestic robot-assisted surgical system deployments (e.g., meerecompany’s Revo-i surgical system and Revo-sim VR training simulators) tailored for micro-incision surgical training in pediatric and neonatal procedures. Additionally, domestic technology giants like Samsung Medison and LG Electronics have integrated AI-enhanced pediatric diagnostic ultrasound software that drastically reduces scan times and radiation exposure for pediatric cardiovascular and fetal imaging.

Market Outlook

• The market is shifting rapidly toward decentralizing pediatric care out of overburdened tertiary medical centers into the home environment. Regulatory updates under the Digital Medical Products Act are expanding reimbursement pathways for connected pediatric wearables, continuous glucose monitors (CGM) for juvenile diabetes, and AI-powered remote respiratory tracking platforms that stream real-time physiological vitals directly to pediatric specialists.
• The MFDS is implementing stricter lifecycle-oriented compliance mandates, specifically targeting Class III and Class IV high-risk pediatric devices, long-term pediatric implants, and software-connected devices. Manufacturers will face expanded requirements for post-market surveillance (PMS), real-world evidence (RWE) tracking, and mandatory cybersecurity validation for all pediatric-grade digital technologies.
• Key associations include Ministry of Food and Drug Safety (MFDS), Korean Association of Medical Device Industry (KMDIA), Korea Health Industry Development Institute (KHIDI), and the Korean Society of Pediatric Cardiology. Key companies are Samsung Medison, LG Electronics, meerecompany, Seegene, Medtronic Korea, GE Healthcare Korea, and Philips Healthcare Korea.

Market Dynamics

Driver: Strong investment in advanced neonatal and pediatric care
South Korea's highly developed healthcare infrastructure and concentration of tertiary children's hospitals continue to drive demand for specialized pediatric medical devices. Hospitals are increasingly investing in advanced neonatal intensive care equipment, pediatric monitoring systems, minimally invasive surgical devices, and AI-enabled diagnostic technologies to improve outcomes for premature infants and children with complex medical conditions. The country's focus on digital healthcare further supports adoption of connected pediatric devices.
Challenge: Stringent reimbursement and regulatory requirements
A major challenge is navigating South Korea's rigorous reimbursement and pricing framework. Pediatric device manufacturers must obtain approval from the Ministry of Food and Drug Safety (MFDS) while also demonstrating clinical value and cost-effectiveness to secure reimbursement through the National Health Insurance system. Because pediatric devices often serve relatively small patient populations, recovering development costs can be difficult under strict pricing controls.
Trend: Growing adoption of AI-integrated pediatric monitoring
Hospitals are increasingly adopting AI-assisted monitoring platforms, wireless patient monitoring, and interoperable neonatal ICU systems. Smart monitoring devices capable of continuous tracking of vital signs and integration with electronic medical records are becoming an important procurement priority, particularly in tertiary hospitals managing critically ill newborns and pediatric patients.

Procurement and Industry Impact

• South Korean hospitals continue to procure high-end pediatric imaging systems, neonatal ventilators, advanced monitoring equipment, and specialized cardiology devices from international manufacturers due to their technological advantages. In 2024, South Korea imported approximately US$4.62 billion worth of medical devices, highlighting the country's continued reliance on advanced imported technologies.
• Procurement is heavily concentrated in large tertiary and university hospitals, where advanced pediatric and neonatal care is delivered. These institutions prioritize clinically validated devices with digital connectivity and long-term service support over low-cost alternatives. Industry analyses indicate that foreign medical devices account for nearly 88.7% of devices used in top-tier tertiary hospitals, reflecting strong demand for premium international technologies.
• Hospital purchasing slowed during the nationwide medical workforce disruptions in 2024–2025, delaying replacement cycles for many medical devices. As hospital operations normalize, procurement departments are resuming deferred purchases of neonatal, pediatric monitoring, and diagnostic equipment, with recovery expected to be driven by replacement demand and continued investment in digital health infrastructure.

Segment Analysis

South Korea Pediatric Medical Devices Market By Product
• South Korea’s pediatric IVD sector is heavily shaped by the Ministry of Food and Drug Safety (MFDS) push for micro-fluidic, low-sample-volume diagnostic kits designed specifically for infants and young children. Local K-Bio diagnostics firms leverage point-of-care PCR and microfluidic chip technology to detect early-onset pediatric infectious diseases and genetic metabolic disorders without requiring large blood draws.
• Pediatric cardiology in South Korea centers on advanced interventional catheterization and micro-sized 3D-printed congenital defect patches. Korean cardiac centers favor ultra-miniaturized transcatheter closure devices and pediatric-grade ECMO (extracorporeal membrane oxygenation) circuits designed to handle low priming volumes for neonates with severe congenital heart abnormalities.
• Given South Korea's high urban density and pediatric asthma prevalence, respiratory devices emphasize precision dosing and low dead-space breathing circuits. Microprocessor-controlled pediatric ventilators and ultra-low-flow anesthetic delivery systems integrated with real-time airway resistance feedback are widely adopted in tertiary medical hubs.
• Despite South Korea’s declining birth rates, the government’s intensive maternal and child health initiatives have concentrated funding into regional high-risk NICU centers. Demand is driven by hybrid incubator-warmers, quiet-environment noise-dampening incubators, and specialized continuous positive airway pressure (CPAP) units tailored for extremely low birth weight (ELBW) infants.
• South Korean pediatric imaging relies heavily on ultra-low-dose pediatric CT protocols, radiation-free point-of-care ultrasound (POCUS), and pediatric-dedicated MRI coil arrays. Domestic imaging leaders prioritize AI-assisted bone age assessment software and automated pediatric organ-segmentation algorithms that minimize repeat scans and sedation requirements.
• The monitoring segment focuses on non-invasive, wearable sensor patches and multiparameter telemetry units designed for delicate pediatric skin. Korean hospitals prioritize wireless pulse oximetry, continuous transcutaneous blood gas monitors, and centralized AI-driven early warning systems that alert clinical staff to subtle physiological deterioration in pediatric wards.
• Other products category encompasses pediatric orthopedic fixation devices, specialized enteral feeding tubes with micro-flow controllers, and micro-dose infusion pumps. There is growing domestic innovation in custom 3D-printed pediatric cranial orthoses for positional plagiocephaly and biocompatible pediatric surgical instruments.

South Korea Pediatric Medical Devices Market By End-User
• Major tertiary academic medical centers and specialized children's hospitals in South Korea serve as the primary buyers of high-spec pediatric technology. These institutions prioritize integrated, multi-modal systems like hybrid pediatric operating suites, ECMO systems, and AI-guided diagnostic infrastructure supported by National Health Insurance (NHI) reimbursement frameworks.
• Community-level pediatric clinics across South Korea are rapidly modernizing to offer rapid point-of-care diagnostics and non-invasive screening tools. The trend shifts clinic purchasing toward portable diagnostic ultrasound, compact ear-tube placement devices, micro-volume blood analyzers, and digital otoscopes that reduce wait times and streamline outpatient triage.
• ASCs in South Korea are adopting specialized pediatric minimally invasive surgical (MIS) instruments and ultra-short-acting anesthetic delivery setups to facilitate same-day discharge. Their focus remains on high-throughput, low-complication tools for routine pediatric procedures such as ENT surgeries, herniotomies, and minor orthopedic interventions.
• Driven by South Korea's advanced digital telecommunications infrastructure and expanding remote monitoring policies, homecare settings are seeing accelerated adoption of pediatric devices. Smart pediatric nebulizers, connected nocturnal pulse oximeters, and mobile app-linked continuous glucose monitors (CGMs) allow parents to manage chronic conditions like childhood asthma and Type-1 diabetes directly from home.
• Government-backed bio-clusters and university-affiliated research labs drive demand for high-throughput pediatric genetic screening platforms and micro-volume IVD automation. These institutes focus on developing native biomarker panels for congenital rare diseases and validating next-generation pediatric-specific medical technologies.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Pediatric Medical Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• In Vitro Diagnostic (IVD) Devices
• Cardiology Devices
• Anesthesia & Respiratory Care Devices
• Neonatal ICU (NICU) Devices
• Diagnostic Imaging Devices
• Monitoring Devices
• Other Products

By End-User
• Hospitals
• Pediatric Clinics
• Ambulatory Surgical Centers (ASCs)
• Home Healthcare / Homecare Settings
• Diagnostic Laboratories & Research Institutes